What is the clinical impact of cerebrospinal fluid biomarkers on final diagnosis and management in patients with mild cognitive impairment in clinical practice? Results from a nation-wide prospective survey in France.

Emmanuel CognatFrançois Mouton LigerAnne-Cécile TroussièreDavid WallonJulien DumurgierEloi MagninEmmanuelle DuronAudrey GabelleBernard CroisileVincent de la SayetteAlain JagerFrederic BlancElodie Bouaziz-AmarCarole Miguet-AlfonsiMuriel QuillardSusanna SchraenNathalie PhilippiEmilie BeaufilsFlorence PasquierDidier HannequinPhilippe RobertJacques HugonClaire Paquetnull null

Published in: BMJ open (2019)

This nation-wide survey, reflecting clinical practice in French memory clinics, describes the impact of CSF AD biomarkers in patients with MCI in clinical practice.

Keyphrases

clinical practice
mild cognitive impairment
cognitive decline
cerebrospinal fluid
cross sectional
primary care
working memory